RION AESTHETICS Wins Octane LaunchPad SBDC Judges Award at Aesthetics Tech Summit

  • RION AESTHETICS awarded top presenting company by Judges at Aesthetics Tech Summit
  • Octane amplifies capital funding strategy for MedTech companies with its Top 5 SBDC ranked accelerator, LaunchPad

Alisa Lask, RION CCO presents to Octane Judging panel. Photo courtesy of Octane SBDC. (Photo: Business Wire)

NEWPORT BEACH, Calif.--()--RION AESTHETICS, a regenerative medicine company pioneering the use of platelet exosomes for skin care and restorative clinical applications, received the prestigious LaunchPad SBDC Judges Award at the 2022 Aesthetics Tech Summit.

“It was an honor to present our groundbreaking technologies to leading physicians, aesthetic experts, investors, and entrepreneurs,” said Alisa Lask, Chief Commercial Officer of RION. “We are thrilled to be the first and only Aesthetics company offering platelet-derived exosomes for use in skincare as well as actively developing restorative clinical applications.

Out of 65 Octane LaunchPad SBDC companies only 7 were selected as finalists using objective scoring methodology that has been in practice for 10+ years. This elite group of companies developing innovative aesthetic technologies, unveiled their technologies in front of a panel of independent judges.

“We are proud to recognize future luminaries as they lead Aesthetics into new areas,” said Director of LaunchPad SBDC, Mike Hill. “Octane and LaunchPad SBDC are thrilled to help assist these companies and most importantly amplify their capital funding structure as they enter this Aesthetic beloved space. We look forward to watching RION AESTHETICS in the coming years.”


RION AESTHETICS is a regenerative medicine company, pioneering the use of platelet exosomes for skin care and restorative clinical applications. Backed by over 15 years of visionary science, we aim to transform skincare through the introduction of Plated™ SkinScience, leveraging the power of exosomes to address the most persistent skin challenges. Beyond skincare, RION AESTHETICS is pursuing FDA approval for Regenosomes, the first room-temperature stable off-the-shelf regenerative exosome that drives soft tissue healing, with the ability to address unmet needs in aesthetics medicine for applications in hair loss, regenerative tissue fillers, and topical nano-toxin technology. Visit


Octane convenes and enables the Southern California tech and medtech business ecosystem by connecting people, resources, and capital. We impact our community through LaunchPad, a top-performing accelerator, Capital & Growth, a platform to provide companies capital and growth resources, Ignite Series, providing leading content, and Octane Foundation for Innovation, focused on furthering our mission while advancing diversity and inclusiveness. Learn more at


Jodi Brichan,


Release Summary

RION AESTHETICS wins Octane LaunchPad SBDC Judges Award at Aesthetics Tech Summit

Social Media Profiles


Jodi Brichan,